Literature DB >> 21341264

Lymphotoxin-β receptor-independent development of intestinal IL-22-producing NKp46+ innate lymphoid cells.

Naoko Satoh-Takayama1, Sarah Lesjean-Pottier, Shinichiro Sawa, Christian A J Vosshenrich, Gérard Eberl, James P Di Santo.   

Abstract

The natural cytotoxicity receptor NKp46 is an activating receptor expressed by several distinct innate lymphoid cell (ILC) subsets, including NK cells, some γδ T cells and intestinal RORγt(+) IL-22(+) cells (NCR22 cells, IL-22-producing NKp46(+) cell). NCR22 cells may play a role in mucosal barrier function through IL-22-mediated production of anti-bacterial peptides from intestinal epithelial cells. Previous studies identified a predominant proportion of NCR22 cells in gut cryptopatches (CP), lymphoid structures that are strategically positioned to collect and integrate signals from luminal microbes; however, whether CP or other lymphoid structures condition NCR22 cell differentiation is not known. Programmed and inducible lymphoid tissue development requires cell-surface-expressed lymphotoxin (LT)α(1) β(2) heterotrimers (provided by lymphoid tissue inducer (LTi) cells) to signal lymphotoxin-β receptor (LTR)(+) stromal cells. Here, we analyzed NCR22 cells in LTβR-deficient Ncr1(GFP/+) mice that lack organized secondary lymphoid tissues. We found that NCR22 cells develop in the absence of LTβR, become functionally competent and localize to the lamina propria under steady-state conditions. Following infection of LTβR(-/-) mice with the Gram-negative pathogen Citrobacter rodentium, IL-22 production from NCR22 cells was not affected. These results indicate that organized lymphoid tissue structures are not critical for the generation of an intact and fully functional intestinal NCR22 cell compartment.
Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21341264     DOI: 10.1002/eji.201040851

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  17 in total

Review 1.  Regional specialization within the intestinal immune system.

Authors:  Allan M Mowat; William W Agace
Journal:  Nat Rev Immunol       Date:  2014-09-19       Impact factor: 53.106

Review 2.  Lymphotoxin organizes contributions to host defense and metabolic illness from innate lymphoid cells.

Authors:  Vaibhav Upadhyay; Yang-Xin Fu
Journal:  Cytokine Growth Factor Rev       Date:  2013-12-24       Impact factor: 7.638

Review 3.  Location and cellular stages of natural killer cell development.

Authors:  Jianhua Yu; Aharon G Freud; Michael A Caligiuri
Journal:  Trends Immunol       Date:  2013-09-19       Impact factor: 16.687

4.  Lymphotoxin controls the IL-22 protection pathway in gut innate lymphoid cells during mucosal pathogen challenge.

Authors:  Alexei V Tumanov; Ekaterina P Koroleva; Xiaohuan Guo; Yugang Wang; Andrei Kruglov; Sergei Nedospasov; Yang-Xin Fu
Journal:  Cell Host Microbe       Date:  2011-07-21       Impact factor: 21.023

Review 5.  Interleukin-22: immunobiology and pathology.

Authors:  Jarrod A Dudakov; Alan M Hanash; Marcel R M van den Brink
Journal:  Annu Rev Immunol       Date:  2015-02-11       Impact factor: 28.527

6.  Type 3 innate lymphoid cell-derived lymphotoxin prevents microbiota-dependent inflammation.

Authors:  Yuan Zhang; Tae-Jin Kim; Joanna A Wroblewska; Vera Tesic; Vaibhav Upadhyay; Ralph R Weichselbaum; Alexei V Tumanov; Hong Tang; Xiaohuan Guo; Haidong Tang; Yang-Xin Fu
Journal:  Cell Mol Immunol       Date:  2017-06-05       Impact factor: 11.530

Review 7.  Lymphotoxin signalling in immune homeostasis and the control of microorganisms.

Authors:  Vaibhav Upadhyay; Yang-Xin Fu
Journal:  Nat Rev Immunol       Date:  2013-04       Impact factor: 53.106

Review 8.  Mucosal Immune Development in Early Life: Setting the Stage.

Authors:  Sylvia Brugman; Olaf Perdijk; R J Joost van Neerven; Huub F J Savelkoul
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2015-02-11       Impact factor: 4.291

9.  IL-22 deficiency alters colonic microbiota to be transmissible and colitogenic.

Authors:  Lauren A Zenewicz; Xiaochen Yin; Guoyang Wang; Eran Elinav; Liming Hao; Liping Zhao; Richard A Flavell
Journal:  J Immunol       Date:  2013-04-12       Impact factor: 5.422

10.  Clinical relevance of natural killer cells following hematopoietic stem cell transplantation.

Authors:  Jeanne M Palmer; Kamalakannan Rajasekaran; Monica S Thakar; Subramaniam Malarkannan
Journal:  J Cancer       Date:  2012-12-05       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.